quinoxalines has been researched along with Retinal Degeneration in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, C; Harada, T; Kimura, A; Mitamura, Y; Namekata, K; Semba, K | 1 |
| Dermon, C; Panagis, L; Prokosch, V; Thanos, S; Volk, GF | 1 |
| Menzler, J; Zeck, G | 1 |
| Babai, N; Luo, J; Margalit, E; Thoreson, WB | 1 |
| Avilés-Trigueros, M; de Imperial, JM; De la Villa, P; García-Avilés, A; López-Herrera, MP; Mayor-Torroglosa, S; Rodríguez, ME; Vidal-Sanz, M; Villegas-Pérez, MP | 1 |
| Chowers, I; Farber, MD; Merin, S; Obolensky, A | 1 |
| Awatramani, GB; Balya, D; Busskamp, V; Cepko, CL; Kim, DS; Lagali, PS; Münch, TA; Roska, B | 1 |
1 trial(s) available for quinoxalines and Retinal Degeneration
| Article | Year |
|---|---|
A pilot study of topical treatment with an alpha2-agonist in patients with retinal dystrophies.
Topics: Administration, Topical; Adolescent; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adult; Aged; Brimonidine Tartrate; Contrast Sensitivity; Electroretinography; Female; Humans; Male; Middle Aged; Patient Compliance; Pilot Projects; Prospective Studies; Quinoxalines; Retinal Degeneration; Retinal Diseases; Retinitis Pigmentosa; Treatment Outcome; Visual Acuity; Visual Fields | 2008 |
6 other study(ies) available for quinoxalines and Retinal Degeneration
| Article | Year |
|---|---|
Brimonidine prevents neurodegeneration in a mouse model of normal tension glaucoma.
Topics: Animals; Brimonidine Tartrate; Excitatory Amino Acid Transporter 3; Female; Glaucoma; Humans; Male; Mice; Mice, Knockout; Protective Agents; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Retinal Degeneration; Retinal Ganglion Cells | 2014 |
Alpha2-adrenergic receptors and their core involvement in the process of axonal growth in retinal explants.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Autoradiography; Axons; Brimonidine Tartrate; Clonidine; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Fluorescent Antibody Technique, Indirect; Glaucoma; Glial Fibrillary Acidic Protein; Optic Nerve Injuries; Organ Culture Techniques; Platelet Activating Factor; Protein Disulfide-Isomerases; Proteomics; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Laminin; Retina; Retinal Degeneration; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2010 |
Network oscillations in rod-degenerated mouse retinas.
Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Age Factors; Animals; Carbenoxolone; Cyclooxygenase Inhibitors; Disease Models, Animal; Evoked Potentials, Visual; Excitatory Amino Acid Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; Gap Junctions; Glutamic Acid; Glycine; In Vitro Techniques; Light; Male; Meclofenamic Acid; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Neurologic Mutants; Nerve Net; Neural Inhibition; Periodicity; Pyridazines; Quinoxalines; Retinal Degeneration; Retinal Rod Photoreceptor Cells; Sodium Channel Blockers; Statistics as Topic; Tetrodotoxin | 2011 |
Inner and outer retinal mechanisms engaged by epiretinal stimulation in normal and rd mice.
Topics: Animals; Biophysics; Calcium; Disease Models, Animal; Electric Stimulation; Evoked Potentials; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA-A Receptor Antagonists; Glycine Agents; In Vitro Techniques; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Microscopy, Confocal; Patch-Clamp Techniques; Picrotoxin; Quinoxalines; Retina; Retinal Degeneration; Retinal Ganglion Cells; Sesterterpenes; Strychnine; Visual Pathways | 2011 |
Ischemia results 3 months later in altered ERG, degeneration of inner layers, and deafferented tectum: neuroprotection with brimonidine.
Topics: Animals; Brimonidine Tartrate; Electroretinography; Female; Ischemia; Ligation; Nerve Degeneration; Neuroprotective Agents; Ophthalmic Artery; Quinoxalines; Rats; Rats, Sprague-Dawley; Retina; Retinal Degeneration; Retinal Ganglion Cells; Retinal Vessels; Superior Colliculi; Time Factors; Visual Pathways | 2005 |
Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Electroporation; Evoked Potentials, Visual; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Light; Luminescent Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Patch-Clamp Techniques; Photic Stimulation; Piperazines; Quinoxalines; Retinal Bipolar Cells; Retinal Degeneration; Retinal Ganglion Cells; Rhodopsin; Time Factors; Vision, Ocular; Visual Pathways | 2008 |